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ABSTRACT
The budding yeast protein, Chl1p, is required for
sister-chromatid cohesion, transcriptional silencing,
rDNA recombination and aging. In this work, we
show that Chl1p is also required for viability when
DNA replication is stressed, either due to mutations
or if cells are treated with genotoxic agents like
methylmethane sulfonate (MMS) and ultraviolet (UV)
rays. The chl1 mutation caused synthetic growth
defects with mutations in DNA replication genes. At
semi-permissive temperatures, the double mutants
grew poorly, were less viable and showed nuclear
fragmentation. They were, however, not limited in
their bulk DNA synthesis. When chl1 cells were
treated with relatively low levels of MMS in S-phase,
they lost viability. The S-phase DNA damage check-
point pathway, however, remained active in these
cells. Agarose gel electrophoresis of genomic DNA
isolated from wild-type and chl1 cells, after recovery
from MMS treatment, suggested that the wild-type
was more proficient in the repair of DNA damage
than the mutant. Our work suggests that Chl1p
is required for genome integrity when cells suffer
endogenously or exogenously induced DNA damage.
INTRODUCTION
High-ﬁdelity transmission of genetic material from parent
cell to daughter cells requires accurate replication and
segregation of chromosomes. Cells having unreplicated, par-
tially replicated or damaged DNA, if allowed to continue
with cell cycle, would generate aneuploidy and genetic
instability. Cells have devised safety mechanisms, the DNA
damage/replication checkpoint machinery, which can sense
the damage or replication blocks and transmit signals to its
components that temporarily halt the progression of the
cycle till the damage is repaired, or cause apoptosis. In the
budding yeast Saccharomyces cerevisiae, the DNA damage
checkpoint pathway involves the two PI3K-like kinases
Mec1 and Tel1, the RFC (replication factor C)-like complex
consisting of RFC1-like protein Rad24p with four small RFC
subunits (Rfc2–Rfc5), the PCNA-like heterotrimeric ring
consisting of Rad17, Ddc1 and Mec3 proteins, and the
MRX complex of proteins, consisting of Mre11, Rad50
and Xrs2. The MRX complex, along with Tel1p, is mainly
required to sense and process double-strand breaks. All the
proteins function in concert as DNA damage sensors by bind-
ing DNA at the site of DNA damage [reviewed in (1–6)].
They transmit the signal to the adaptor/mediator molecule,
Rad9, which is activated by phosphorylation in a Mec1/
Tel1-dependent fashion. Activated Rad9p binds to the
effector kinase Rad53 (Chk2) that then gets activated by
Mec1/Tel1-dependent phosphorylation (7–9). Activation of
Rad53p, which is a major effector kinase in S-phase, turns
on the transcription of genes required for damage repair,
prevents late origins from ﬁring so that DNA synthesis in
S-phase is regulated, helps in stabilizing the existing forks
and restrains spindle elongation in early S-phase (10–20).
Methylmethane sulfonate (MMS), a DNA alkylating drug,
can cause nicks and gaps in DNA, resulting in cell death and
defective S-phase regulation in checkpoint mutants mec1,
rad53, rad24, rad17 and rad9 (21). Unrepaired single-strand
breaks can give rise to double-strand breaks (22). When DNA
is alkylated by MMS, S-phase progression is slowed down,
presumably due to the stalling of forks when they encounter
alkylated DNA. The checkpoint proteins Mec1 and Rad53
are required to prevent these stalled forks from collapsing
irreversibly, thus permitting continuation of DNA replica-
tion and preserving cell viability (16,17). At low levels
of drug concentrations, DNA damage activates Rad53p only
in S-phase and requires the formation of replication
forks (23).
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identify genes required for the initiation of DNA replication
(24). mcm1–mcm7 and mcm10 have identiﬁed genes, which
affect the initiation of DNA replication at yeast chromo-
somal replication origins [reviewed in (25–27)]. In this
work, we have cloned a hitherto uncharacterized MCM
gene, MCM12, and show that it is the same as Chl1p. In
the previous studies, Chl1p has been shown to be required
for chromosome segregation (28,29) and for sister-chromatid
cohesion in mitosis and meiosis (30–32). Mating-type inter-
conversion studies have suggested its possible role in chro-
matin structure (33). Recent work has documented its
involvement in transcriptional silencing, rDNA recombina-
tion and aging (34). CHL1 has 23% identity to the nucleotide
excision repair gene RAD3, contains all seven consensus
motifs found in helicases belonging to DEAH helicase family
(29), has an essential ATP-binding site and is localized in the
nucleus (30,35). It also has three highly related human
homologs, BACH1, hChlR1 and hChlR2. Of these, hChlR1
shows in vitro DNA helicase activity and binds to both
single- and double-stranded DNA (30,36,37). BACH1 is a
member of the DEAH helicase family and binds to the
tumor suppressor protein BRCA1, contributing towards its
DNA repair activity (38).
In this work, we show that budding yeast Chl1p is required
in S-phase for preserving cell viability when the DNA dam-
age occurs by endogenous causes such as mutations, or by
exogenous agents like MMS and UV rays. We also show
that chl1 cells lose viability because they are deﬁcient in
the repair of MMS-induced DNA damage.
MATERIALS AND METHODS
Media and chemicals
Media has been described before (39). Restriction enzymes
and other modifying enzymes were from New England
Biolabs (USA), Bethesda Research Laboratories (BRL),
USA and Bangalore Genei Pvt. Ltd (India). Proteinase K
was from Boehringer Mannheim, Germany. Glusulase was
from DuPont Company, USA, and Zymolyase 100T was
from Seikagaku Kogyo Company Limited, Japan. Low melt-
ing agarose, propidium iodide, 40,6-diamidino-2-phenylindole
(DAPI), alpha-factor and goat anti-rat alkaline phosphatase-
conjugated secondary antibody were from Sigma. Rat mono-
clonal antibody, YOL1/34 (40) directed against alpha-tubulin
from yeast was from Serotec. Rad53 goat polyclonal anti-
body, raised against a C-terminus peptide of yeast Rad53p,
and secondary alkaline phosphatase-conjugated anti-goat
antibody were from Santa Cruz Biotechnology, USA. NBT/
BCIP (Nitro-Blue Tetrazolium Chloride/5-Bromo-4-Chloro-
30-Indolyphosphate p-Toluidine Salt) was from Bangalore
Genei Pvt Ltd. MMS was from SRL (India). For irradiation
with UV rays, the source was a germicidal UV lamp (NIS
G30T8, 30 W, length 86 cm). The plates were kept at a
distance of 95 cm from the UV source.
Strains and plasmids
The plasmid YIplac211 is described in (41). YCp1 (carrying
ARS1) and YCp121 (carrying ARS121) have been described
in (24). YCp101 (ARS1 CEN5 LEU2) was from B.-K. Tye
(42). Table 1 gives the list of strains used. Strain 699 and
all the strains listed below it were in W303 background
while the parent strains of the remaining were from
G. Fink. The construction of double mutants and deletions
of SGS1, CHL1 and BAR1 are described under Supplemen-
tary Data.
Cell synchronization, flow cytometry, cell viabilities
and nuclear staining
Cells were synchronized in G1 phase using alpha-factor as
described in (43) and processed for ﬂow cytometry according
to (44). For measuring cell viabilities, aliquots of cells were
removed at indicated times, counted, appropriately diluted
and plated in duplicate on YEPD plates. Cell viability was
the fraction of plated cells which gave visible colonies after
3 to 4 days of growth at permissive temperatures on YEPD
plates. Viabilities were normalized with respect to initial val-
ues at 0 time points. Cells were ﬁxed for 30 min using 70%
ethanol, washed with water and nuclei were stained using
DAPI (45). Around 150–200 cells were counted for data
involving cell cycle arrests and nuclear morphologies, using
a ﬂuorescence microscope (Leica ﬁtted with DC 300F
camera).
Protein extractions, western blots
For western blot analysis, protein extracts were prepared
according to (8) from cells synchronized in G1 and released
in YEPD medium containing 0.035% MMS. Proteins were
separated on 8% SDS–PAGE containing an acrylamide to
bis-acrylamide ratio of 80:1 and transferred to polyvinylidene
diﬂuoride (PVDF) membrane (Schleicher and Schuell).
Rad53 was detected using anti-Rad53 goat polyclonal anti-
body at 1:1000 dilution in TBS (50 mM Tris buffer pH 7.5,
150 mM NaCl) containing 0.5% BSA for 12–16 h. Secondary
alkaline phosphatase-conjugated anti-goat antibody was incu-
bated with the membrane for 2 h at 1:2500 dilution.
Preparation of DNA in agarose plugs and agarose
gel electrophoresis for DNA repair
Overnight cultures of cells were re-inoculated in liquid YEPD
(at temperatures described in the text for different strains) and
grown for 3–4 h to an OD610 of  0.8. Cells were synchro-
nized in G1 using alpha-factor, released from arrest in the
original volumes of YEPD, divided into two halves, one con-
taining the indicated concentration of MMS and the other was
left untreated. After 30 min of shaking at 28 C, equal volume
of 10% sodium thiosulphate was added to each culture and
cells were washed quickly at room temperature. The cells
were then released in original volumes of fresh YEPD med-
ium and aliquots were withdrawn at various time intervals.
DNA from these cells was prepared in agarose plugs (inserts)
according to (46). Brieﬂy, cell pellets were washed twice with
50 mM EDTA (pH 8.0) and resuspended in 400 mlo ft h e
same solution to a concentration of  0.5 · 10
10 cells/ml.
Equal volume of 1% low melting agarose at 37 C was
added to the cell suspension and zymolyase 100T was
added to this mixture to a ﬁnal concentration of 20 mg/ml.
This mixture was distributed into 100 ml moulds (Bio-Rad
mould chamber) and allowed to solidify for 30 min on ice.
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EDTA pH 8.0 and 7.5% b-mercaptoethanol (2 to 3 plugs
per ml) for spheroplasting. Next day the plugs were trans-
ferred to ESP (0.5 M EDTA pH 9.0, 1% laurylsarcosine
and 1 mg/ml proteinase K) and kept at 50 C for 48 h. The
plugs were stored at 4 C in 0.5 M EDTA pH 8.0. DNA in
these plugs was electrophoresed by conventional one-
dimensional agarose gel (0.5%) electrophoresis at 2.5 V/cm
for 28 h in TBE (0.089 M Tris borate, 0.089 M boric acid
and 0.002 M EDTA) buffer.
RESULTS
The chl1 mutation shows synergistic growth defects
with mutations in genes required for DNA replication
Cloning and sequencing of the MCM12 gene showed it to
be the same as CHL1 (Supplementary Data). Therefore, in
this work MCM12 and Mcm12p will be referred to as
CHL1 and Chl1p, respectively. The chl1 null mutant carries
the chl1::HIS3 disruption mutation made in this study
(Supplementary Figure 1s).
The mcm mutants have been found to affect chromosome
replication or segregation (25). chl1 is known to cause chro-
mosome missegregation due to defects in sister-chromatid
cohesion (30,31). To study the role, if any, of Chl1p/
Mcm12p in chromosome replication, genetic interactions of
chl1 with mutations in genes required for DNA replication
were studied. MCM2, CDC6, ORC2 and ORC5 are all essen-
tial genes that are required for the initiation of DNA replica-
tion while MCM2 is also required for elongation (25,27). It
was reasoned that synthetic lethality of chl1 with a mutation
in any of these genes would indicate the involvement of
Chl1p with some aspect of DNA replication.
Double mutants, mcm2-1 chl1::HIS3, orc5-1 chl1::HIS3
and cdc6-3 chl1::HIS3 were tested for growth at various
temperatures. All these double mutants exhibited synergistic
growth defects at 32 C (Figure 1A and B). To show that these
genetic interactions were speciﬁc to the chl1 mutation, double
mutants mcm2-1 chl4::HIS3 and mcm2-1 mcm21-D2::LEU2
were also constructed, where chl4::HIS3 and mcm21-
D2::LEU2 are mutations in genes coding for kinetochore
proteins (47,48). However, mcm2-1 chl4::HIS3 and mcm2-1
mcm21-D2::LEU2 did not display any synergistic growth
defects (Figure 1B), suggesting that mcm2-1 shared a speciﬁc
interaction with chl1/mcm12 and not with mcm mutations
affecting kinetochore proteins. orc2-1 was found to be syn-
thetically lethal with chl1 null mutation (Supplementary
Data). A study of cell viabilities showed that, when compared
with the single mutant mcm2-1 (SL13), the double mutant
mcm2-1 chl1 (SL13Dchl1) displayed a steady fall in viability
at 32 C (Figure 2A). Similarly, double mutants orc5-1
chl1::HIS3 and cdc6-3 chl1::HIS3 also lost viability
more rapidly than the single mutants (orc5-1, cdc6-3 and
Table 1. Strains used in this study
Strain Genotype Sources/References
A3 MATa leu2-3, 112 his3-11, 15 (24)
AP22 MATa leu2-3, 112 his3-11, 15 ura3-52 trp1 (34)
R67 MATa leu2 ura3 his4 mcm12-1 From B.-K. Tye
M11 MATa leu2 ura3 his4 mcm12-2 (24)
8534-8C MATa his4D34 ura3-52 leu2-3,112 (24)
A3Dchl1 MATa leu2-3, 112 his3-11, 15 chl1::HIS3 This study
AP22D22 MATa leu2-3, 112 his3-11, 15 ura3-52 trp1 mcm22-D1::TRP1 By deleting AP22 (44)
AP22Dchl1 MATa leu2-3, 112 his3-11, 15 ura3-52 trp1 chl1::HIS3 (34)
M46-3C MATa leu2-3, 112 his3-11, 15 ura3-52 mcm2-1 (24)
M46-3CDchl1 MATa leu2-3, 112 his3-11, 15 ura3-52 mcm2-1 chl1::HIS3 This study, by disrupting CHL1 in M46-3C
M46-3CD21 MATa leu2-3, 112 his3-11, 15 ura3-52 mcm2-1 mcm21-D2::LEU2 This study
M46-3CDchl4 MATa leu2-3, 112 his3-11, 15 ura3-52 mcm2-1 chl4::HIS3 This study
SL13 MATa leu2-3, 112 his3-11, 15 ura3-52 mcm2-1 By crossing M46-3CDchl1 with A3
SL13Dchl1 MATa leu2-3, 112 his3-11, 15 ura3-52 mcm2-1 chl1::HIS3 This study, by disrupting CHL1 in SL13
699 MATa ade2-1 trp1-1 leu2-3, 112 his 3-11, 15 ura3 can1-100 Uttam Surana
699Dchl1 MATa ade2-1 trp1-1 leu2-3, 112 his 3-11, 15 ura3 can1-100 chl1::HIS3 This study, by disrupting CHL1 in 699
SL14 MATa ade2-1 trp1-1 leu2-3, 112 his 3-11, 15 ura3 can1-100 bar1::LEU2 This study, by disrupting BAR1 in 699
SL14Dchl1 MATa ade2-1 trp1-1 leu2-3, 112 his 3-11, 15 ura3 can1-100 chl1::HIS3 bar1::LEU2 This study, by disrupting BAR1 in 699Dchl1
699Dsgs1 MATa ade2-1 trp1-1 leu2-3, 112 his 3-11, 15 ura3 can1-100 sgs1D::LEU2 This study, by deleting SGS1in 699
699Dsgs1Dchl1 MATa ade2-1 trp1-1 leu2-3, 112 his 3-11, 15 ura3 can1-100 sgs1D::LEU2 chl1::HIS3 This study, by disrupting CHL1 in 699Dsgs1
US456 MATa leu2 his3 trp1 ade2 rad24::URA3 Uttam Surana
SL3 MATa leu2 his3 trp1 ade2 rad24::URA3 By crossing US456 with 699Dchl1
SL3Dchl1 MATa leu2 his3 trp1 ade2 rad24::URA3 chl1::HIS3 From SL3, by disrupting the CHL1gene
SL4 MATa leu2 his3 trp1 ade2 rad24::URA3 chl1::HIS3 By crossing US456 with 699Dchl1
SS1 MATa leu2 his3 trp1 ade2 rad24::URA3 bar1::LEU2 From SL3, by disrupting the BAR1gene
SS1Dchl1 MATa leu2 his3 trp1 ade2 rad24::URA3 chl1::HIS3 bar1::LEU2 From SL3Dchl1, by disrupting the BAR1gene
US354 MATa leu2 his3 trp1 ade2 ura3 rad53-21 Uttam Surana
SL7 MATa leu2 his3 trp1 ade2 ura3 rad53-21 By crossing US354 with 699
SL7Dchl1 MATa leu2 his3 trp1 ade2 ura3 rad53-21 chl1D::TRP1 This study, by deleting CHL1in SL7
US3138 MATa ade2-1leu2-3,112 trp1-1 his3-11,15ura3 can1-100 bar1 GAL psi
+mec1-1 Uttam Surana
YB0297 MATa ade2 leu2 trp1 his3 can1 GAL psi
+cdc6-3 From B.-K. Tye
YB0297Dchl1 MATa ade2 leu2 trp1 his3 can1 GAL psi
+cdc6-3 chl1::HIS3 This study, by disrupting CHL1 in YB0297
JRY4490 MATa can1-100 his3-11 leu2-3, 112 lys2D trp1-1 ura3-1 orc2-1 From B.-K. Tye
JRY4245 MATa ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 ura3-1 orc5-1 From B.-K. Tye
JRY4245Dchl1 MATa ade2-1 can1-100 his3-11 leu2-3, 112 trp1-1 ura3-1 orc5-1 chl1::HIS3 This study, by disrupting CHL1 in JRY4245
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(Figure 2F).
At non-permissive temperatures, the mcm2-1 mutation is
known to cause DNA damage and cell cycle (late S/G2/M)
arrest which is RAD9 dependent (46,49,50). This arrest
is characterized by the accumulation of large-budded
uni-nucleated cells with the nucleus mostly at the neck or
stretched through it. An examination of the mcm2-1 and
mcm2-1 chl1 cell cultures showed that a higher percentage
of mcm2-1 chl1 cells were present as large-budded cells
arrested with single nucleus at the neck (Table 2).
Fluorescence-activated cell sorting (FACS) analysis of cells
growing exponentially at 32 C (4 and 8 h; Fig 2B) showed
that most of mcm2-1 chl1 cells had a near 2n DNA content,
suggesting that these cells were spending more time at G2/M.
At 24 h, wild-type, mcm2-1 and chl1 cells proceeded towards
stationary phase, as G1 (single) cells started to accumulate
in the cultures. At this time point, mcm2-1 chl1 cells still
showed a high percentage of arrested large-budded cells
(Table 2). It may be mentioned that chl1 cells also pause at
G2/M due to defects in sister-chromatid cohesion and inde-
pendent of the DNA damage checkpoint (29,30). However,
the fraction of arrested cells in mcm2-1 chl1 culture was
more than additive of the single mutants, especially at later
time points, suggesting that factors other than sister-
chromatid cohesion were involved in causing G2/M arrest
in the double mutant. The simplest explanation for the syner-
gistic effects observed between mcm2-1 and chl1 mutations is
that the double mutant cells were accumulating higher DNA
damage than mcm2-1 cells and were arrested at G2/M for
longer times to repair the damage.
The double mutant culture was also marked by the pres-
ence of cells with fragmented nuclei after prolonged growth
at 32 C (Figure 2C). Nuclear fragmentation could be seen
in all cell types—singles, large-budded with single nucleus
(arrested) or large-budded with segregated nuclei. Perhaps
this last category of cells were entering catastrophic mitosis,
overcoming the DNA damage checkpoint without repair of
DNA damage. The fraction of cells with fragmented nuclei
increased progressively with continued incubation at 32 C
(Table 3). The extent of fragmentation also increased during
this time interval in that cells with highly fragmented
nuclei started to appear at later time points. The fraction
of such cells in cultures of other strains (wild-type and the
single mutants) remained <5% at all times during growth
at 32 C.
Cultures of orc5-1 chl1 grown for 4.5 h at 32 C also had
a greater fraction of arrested cells with fragmented
nuclei when compared with the single mutants (Table 4,
Figure 2G). Under same conditions of growth, cdc6-3 and
cdc6-3 chl1 cells displayed similar fractions of large-budded
uni-nucleated (arrested) cells in their respective cultures
(Table 4). cdc6-3 chl1 cells were, however, abnormally
large, looked sick and displayed extensive nuclear fragmenta-
tion as opposed to cdc6-3 cells (Figure 2G, Table 4).
Thus, replication defects in these mutants were exacerbated
by chl1 and suggested a role of Chl1p in the maintenance of
DNA integrity in replication mutants. One possibility was
Chl1p’s involvement in the initiation or for some other aspect
of DNA replication, due to which the double mutants dis-
cussed above could be severely compromised in the synthesis
of their DNA. A comparison of S-phase progression of wild-
type and mutant cells at 32 C showed that chl1 cells pro-
gressed at the same rate as the wild-type, reaching G2 within
40 min (Figure 2D). The budding index (Figure 2E) showed
that both the strains entered S-phase at similar timings. This
shows that the absence of Chl1p does not affect bulk DNA
synthesis. As expected, the replication mutant mcm2-1 syn-
thesized DNA more slowly, taking 60 min to reach G2. If
chl1 affected the efﬁciency of replication origin usage and
mcm2-1 chl1 cells were growing poorly because of synergis-
tic deﬁciency in origin utilization, then the double mutant was
expected to synthesize DNA more slowly than mcm2-1. This,
however, was not the case. On the contrary, mcm2-1 chl1
cells progressed somewhat faster than the mcm2-1 cells.
The budding index (Figure 2E) showed that mcm2-1 and
mcm2-1 chl1 cells entered S-phase at about the same time.
This result was reproducible in three experiments. Similar
results were obtained with orc5-1 and orc5-1 chl1 (not
shown). Therefore, chl1 cells were not limited in the utiliza-
tion of their replication origins nor in bulk DNA synthesis.
This was further corroborated by the observations that chl1
mutation did not show ARS-speciﬁcity nor ARS-dosage-
dependence in the maintenance of minichromosomes (51).
Furthermore, chl1 enhanced chromosome loss rate but did
not signiﬁcantly elevate genetic recombination frequency,
making it unlikely that Chl1p has a major role in DNA
replication (29,51,52).
The chl1 null mutant is more sensitive than the
wild-type to MMS and UV rays
Cells carrying defects in DNA damage repair or checkpoint
pathways are more sensitive to killing by DNA damaging
agents like UV rays and the DNA alkylating drug MMS. In
genome-wide screens, it has been reported that chl1 deletion
mutant is hypersensitive to MMS (53,54). Our own results
showed the same. AP22Dchl1 (chl1), AP22D22 [deleted for
MCM22 that codes for a kinetochore protein (44)] and the
wild-type strain, AP22, were all tested for their sensitivities
Figure 1. (A and B) Genetic interactions of chl1::HIS3 with mutations in
DNA replication genes. Cells were streaked on YEPD plates, which were
incubated at indicated temperatures for 2 days. The strains used were wild-
type (wt), AP22; chl1, AP22Dchl1; cdc6-3, YB0297; orc5-1, JRY4245;
mcm2-1, M46-3C; Double mutants were constructed by disrupting/deleting
CHL1, CHL4 or MCM22 in these strains as described in Supplementary Data.
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sensitivity towards this drug (Figure 3A), the kinetochore
mutant mcm22 grew like the wild-type. Cell viabilities of
chl1 and wild-type cells in the presence of 0.035% MMS
conﬁrmed these results (not shown). MMS-treated cultures
of mutant and wild-type cells showed >80% accumulation of
G2/M-arrested large-budded cells, each with a single nucleus
at the neck or stretched through it (not shown), suggesting
that the G2/M DNA damage checkpoint pathway is func-
tional in the mutant.
Figure 2. Cell viability, G2/M arrest and nuclear fragmentation in wild-type, chl1, mcm2-1 and mcm2-1 chl1 cells. A3 (MCM2 CHL1), A3Dchl1 (MCM2 chl1),
SL13 (mcm2-1 CHL1) and SL13Dchl1 (mcm2-1 chl1) cells were grown in YEPD at 23 C to log-phase and re-inoculated at 32 C in pre-warmed YEPD medium.
Aliquots were removed at various times for determining cell viabilities (A), for fluorescence activated cell sorting (FACS) analysis (B) and stained with DAPI for
nuclear morphology (C). Samples from a few representative time points are shown for (B) and (C) h, hours. (D and E) The same strains were arrested in G1 using
alpha-factor and released at 32 C in fresh YEPD. Aliquots were removed at time intervals for monitoring S-phase progression using flow cytometry and for
budding index (fraction of cells that had initiated budding after release from G1 arrest). (F) Cell viabilities of wild-type, chl1, orc5-1, orc5-1 chl1, cdc6-3 and
cdc6-3 chl1 grown at 32 C. 699 (wild-type), 699Dchl1 (chl1), JRY4245 (orc5-1), JRY4245Dchl1 (orc5-1 chl1), YB0297 (cdc6-3) and YB0297Dchl1 (cdc6-3
chl1) were grown to exponential phase in liquid YEPD at 23 C, re-inoculated into pre-warmed liquid YEPD at 32 C and processed for the determination of cell
viabilities as in (A). (G) Nuclear fragmentation in orc5-1 chl1 and cdc6-3 chl1 cells. JRY4245 (orc5-1), JRY4245Dchl1 (orc5-1 chl1), YB0297 (cdc6-3) and
YB0297Dchl1 (cdc6-3 chl1) were grown to exponential phase in liquid YEPD at 23 C, re-inoculated into pre-warmed liquid YEPD at 32 C and grown for 4.5 h.
Thereafter, cells were stained with DAPI and analyzed for their morphologies using the fluorescence microscope. Abbreviations: h, hours; min, minutes; exp,
exponential.
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susceptible to killing by UV damage, we compared the
cell-viabilities of the wild-type AP22, the chl1 disruption
mutant AP22Dchl1 and the kinetochore mutant AP22D22,
in response to different dosages of UV irradiation.
Figure 3B shows that AP22Dchl1 was more sensitive towards
killing by UV irradiation than the wild-type or the kineto-
chore mutant AP22D22.
The chl1 mutant is proficient in DNA damage
checkpoint pathway
The observations that the chl1 null mutation gives synergistic
growth defects with DNA replication mutants, shows hyper-
sensitivity to genotoxic agents like UV rays and MMS, causes
chromosome loss without signiﬁcant increase in genetic
recombination rates, suggests that Chl1p could be involved
in DNA damage repair or in checkpoint function or both.
Although the presence of arrested cells in MMS-treated
chl1 cultures and in double mutants described above sug-
gested that the DNA damage checkpoint pathway was active
in these cells, we decided to check on this pathway by more
direct experiments, as described below.
When replication forks stall in the presence of MMS,
S-phase is slowed down (16,21). However, when DNA is
damaged in some S-phase checkpoint mutants such as
mec1, rad9, rad17, rad24 and rad53, S-phase appears to pro-
gress faster because late origins ﬁre inappropriately, causing
additional DNA synthesis, which can be detected by ﬂow
cytometry (16,21). To test whether Chl1p had an intra S-
phase checkpoint function, the progression of the cell cycle
was studied in cells synchronized with alpha-factor. rad24
(SL3) and rad53-21 (SL7) mutants were also included in
these studies, as they are known to be defective in regulating
their DNA synthesis when it is damaged. After their release
from alpha-factor, the cells were resuspended in fresh med-
ium containing 0.035 % MMS and the progression of cells
across S-phase were monitored by ﬂow cytometry. After 80
min of treatment with MMS, both chl1 and wild-type strains
were still in S-phase (Figure 4A). In contrast to chl1, rad24
Table 2. chl1enhances the cell cycle arrest phenotype of mcm2-1cells
Strain Hours at 32 C
0482 4
% Large-budded % Arrested % Large-budded % Arrested % Large-budded % Arrested % Large-budded % Arrested
(MCM2 CHL1) 11 0 7.4 0.7 3 0 4.7 0.8
(MCM2 chl1) 27 7 15 6.4 17 9.2 2.3 0.6
(mcm2-1 CHL1) 17 1 42 23 35 16 27 10
(mcm2-1 chl1::HIS3) 3 01 5 6 54 3 7 74 7 6 02 6
Cells from Figure 2 were analyzed forcell cycle arrest(percent large-budded cells in the culture)and nuclear morphology(percentlarge-buddedcells in the culture
which had single nucleus at the neck or stretched through it). About 150–200 cells were analyzed in each case.
Table 3. mcm2-1 chl1 cells show increased fragmentation of nuclei at 32 C
Strain % Cells with fragmented nuclei
0h 4h 1 0h 2 4h
MCM2 CHL1 3.1 0.7 <0.6 0.8
MCM2 chl1 1.7 2.0 <0.6 0.6
mcm2-1 CHL1 1.2 3.5 5.1 1.3
mcm2-1 chl1 6.6 13 24 36
Cells from Figure 2A were analyzed for fragmented nuclei by staining DNA
with DAPI.;  150–200 cells were analyzed in each case. ‘Hours’ refer to
incubation time at 32 C.
Table 4. Cell and nuclear morphology in orc5-1, orc5-1 chl1, cdc6-3 and
cdc6-3 chl1 mutant cells after 4.5 h of growth at 32 C
Strain Cell and nuclear morphology
% Large-budded % Arrested % Fragmented nuclei
orc5-1 25 7.3 3.3
orc5-1 chl1 54 33 19
cdc6-3 72 62 5.3
cdc6-3 chl1 69 53 33
Cells from Figure 2G were analyzed for cell and nuclear morphologies as
described under Table 2. Figure 3. The chl1 mutation confers growth sensitivity in the presence of
MMS and UV rays. (A) Spot assay for MMS sensitivity of chl1::HIS3
(AP22Dchl1), AP22D22 (mcm22-D1::TRP1), and wild-type (AP22) strains.
Growing cells were serially diluted and spotted on YEPD plates containing
0.025% MMS or no MMS (control). The YEPD plate was incubated at 30 C
for 2 days while the MMS-containing plate was incubated at the same
temperature for 3–4 days. (B) chl1 mutation confers hypersensitivity to UV
rays. Exponentially growing cells, appropriately diluted, were plated on
YEPD plates, exposed to UV rays for various times and incubated in the dark
at 30 C. Control plates were also kept which were not irradiated and were
used to calculate total number of cells plated. Colonies were counted after
2–3 days of incubation. Results are the mean values of four independent
experiments and error bars are SD values from the mean.
Nucleic Acids Research, 2006, Vol. 34, No. 20 5885and rad53-21 mutants continued to synthesize DNA whose
content reached G2 within 60 min of release from G1 arrest.
The double mutant rad24 chl1 was not very different from the
single mutant rad24, in so far as the time taken to reach G2
DNA content was concerned. Since the S-phase progressions
in chl1 and wild-type cells were similar in the presence of
MMS, it suggests that the DNA damage checkpoint pathway
was mostly active in these cells.
Figure 4. DNA damage checkpoint is active in chl1 mutant cells. (A) S-phase progression of mutant and wild-type cells in the presence of MMS. 699 (CHL1
RAD24 RAD53), 699Dchl1 (chl1), SL3 (rad24), SL4 (rad24 chl1) and SL7 (rad53-21) cells were all synchronized with alpha-factor, washed free of alpha-factor,
resuspended in pre-warmed YEPD medium at 30 C, divided into two parts and MMS was added to a final concentration of 0.035% to one part. Both the cultures
were kept shaking at 30 C. Aliquots were removed at various times for FACS analysis. Arrows indicate G1 and G2 DNA contents. (B) chl1 are proficient in
Rad53p phosphorylation in response to MMS treatment in S-phase. SL14 (CHL1 RAD24), SL14Dchl1 (chl1), SS1 (rad24) and SS1Dchl1 (rad24 chl1) were
arrested in G1 phase and released in fresh YEPD medium containing 0.035% MMS at 30 C. Rad53p phosphorylation was detected by western blot analysis of
proteins extracted from aliquots of cells removed at indicated times, using antibodies directed against the Rad53 protein. (C) DNA content of cells from the same
aliquots analyzed by flow cytometry. (D) chl1 cells are hypersensitive towards killing by MMS in S-phase. 699 (wild-type), 699Dchl1 (chl1), SL3 (rad24),
SL3Dchl1 (rad24 chl1), 699Dsgs1 (sgs1), 699Dsgs1Dchl1 (sgs1 chl1), SL7 (rad53-21), SL7Dchl1 (rad53-21 chl1) cells were arrested by alpha-factor in G1 and
released in fresh YEPD containing 0.035% MMS. Aliquots were removed for cell viabilities and for DNA content. Data are averages of two independent
experiments which gave very similar results. Bars are deviations from the average values and are not shown in rad24 and rad24 chl1 series for the sake of clarity
in rad53 and rad53 chl1 series. (E) DNA content of cells in (D) measured by flow cytometry. Arrows indicate G1 and G2 DNA contents. Abbreviations are as in
Figure 2.
5886 Nucleic Acids Research, 2006, Vol. 34, No. 20To conﬁrm this, Rad53p activation was studied directly
by assaying for its phosphorylation in MMS-treated cells.
Cells were synchronized with alpha-factor and released
in YEPD in the presence of 0.035% MMS. Aliquots were
withdrawn at indicated times. Figure 4B and C show that
chl1 cells had Rad53p phosphorylated to the same levels as
the wild-type in S-phase. rad24 cells, as expected, showed
much lower levels of Rad53p phosphorylation while rad24
chl1 mutant was no different than rad24. Thus, Chl1p is
not required to activate the DNA damage checkpoint pathway
when cells are treated with MMS in S-phase.
Finally, it was found that S-phase chl1 cells were sig-
niﬁcantly more sensitive towards killing by MMS than the
wild-type. Mutant and wild-type cells were synchronized in
G1, released in S-phase and exposed to 0.035% MMS for
varying times. Figure 4D and E show the viability curve.
chl1 cells were more prone than the wild-type towards killing
by the drug while rad24 and rad53-21 displayed very low
viabilities. The fall in the viability of chl1 cells was additive
with both rad24 and rad53-21 mutants in that rad24 chl1 and
rad53-21 chl1 cells showed even lower viabilities than the
single mutants. rad53-21 is a null mutation in so far as its
role in DNA replication/damage checkpoint pathways is con-
cerned (55). Higher cell death in rad53-21 chl1 cells, as com-
pared with rad53-21 cells, suggested that Chl1p was required
in addition to the DNA damage checkpoint pathway to main-
tain viability when cells were treated with MMS in S-phase.
Sgs1p is a member of the RecQ family of helicases which
are involved in maintaining genome stability (56,57). In
yeast, Sgs1p is a component of the DNA replication check-
point pathway which gets activated upon a block in replica-
tion (58). sgs1 chl1 double mutant was included to see if
there was a functional overlap between the two helicases,
Chl1p and Sgs1p, that would give synergistic loss in cell via-
bility. Figure 4D shows that the sgs1 mutant displayed the
same viability as the wild-type and did not display any syn-
thetic interactions with chl1. Therefore, unlike Chl1p, Sgs1p
does not play a major role in maintaining genome integrity
when cells suffer limited DNA damage in S-phase by low
concentrations (0.035%) of MMS. The DNA damage check-
point pathway, involving Rad24p, appears to be the major
route for the maintenance of genome stability under these
conditions.
Chl1p is required in S-phase for MMS-induced
DNA damage repair
To determine if Chl1p was required for the repair of DNA
damage inﬂicted in S-phase by MMS, mutant and wild-type
cells were synchronized with alpha-factor and released in
YEPD containing MMS. After a period of treatment with
MMS, the cells were released in fresh YEPD medium without
the drug and grown to repair the damage. We argued that if
the mutant DNA had more unrepaired nicks and gaps than the
wild-type DNA, double-strand breaks would be generated
(22,59) and the average size of mutant DNA would be lesser
than that of the wild-type (Figure 5A). This difference would
manifest itself during the movement of DNA through
agarose.
Wild-type and chl1 cells were released from alpha-factor
arrest into YEPD containing 0.01%, 0.02% and 0.04%
MMS. Control cells were also maintained under similar con-
ditions without MMS. After 30 min, MMS treatment was
stopped, cells were washed and grown in YEPD for further
periods of 1 and 2 h to allow for recovery from DNA damage.
Genomic DNA isolated in agarose plugs (to avoid shearing)
from all these time points was run on a 0.5% agarose gel
as described in the Methods section. Figure 5B shows that
after 1 h recovery period, DNA from cells treated with
progressively higher concentrations of MMS showed a pro-
gressive increase in DNA mobility, suggestive of the pres-
ence of DNA having lower average molecular weight.
Thus, the extent of MMS treatment corresponded with the
level of DNA damage. MMS-treated DNA from mutant
cells showed higher mobility than corresponding cells from
the wild-type, suggestive of the presence of additional dam-
age in the DNA of mutant cells. After an additional hour of
recovery, DNA from MMS-treated wild-type cells began
to migrate close to DNA from untreated cells. However,
DNA from MMS-treated mutant cells still lagged behind in
upward shift, showing a slow recovery from DNA damage.
The FACS proﬁle of the cells treated with 0.04% MMS
(Figure 5C) showed that most of the cells from the two strains
were arrested in G2 phase of the cell cycle.
We next performed the same experiment using 0.035%
MMS which we have used for viabilty and other studies in
this work. The DNA replication and damage checkpoint
mutant, mec1-1, was also included as a control. DNA was iso-
lated from these cells in agarose plugs and it was run in 0.5%
agarose gel. After 30 min treatment in the presence of MMS,
the cells, still in S-phase (Figure 5D), were released in fresh
YEPD medium and allowed to grow for 60, 90 and 120 min
to repair the damage. Genomic DNA from both chl1 and
mec1-1 cells, isolated 60 min after treatment with MMS
(1 h repair period), moved faster than the wild-type DNA iso-
lated under similar conditions (Figure 5E). Assuming that the
level of DNA damage inﬂicted by MMS was the same in
wild-type and mutant cells, it is reasonable to deduce that
the higher mobility of mutant DNA was due to the inability
of these cells to repair DNA damage at the same pace as
the wild-type cells. chl1 and mec1-1 cells approached or
reached G2 phase without repairing their DNA damage to
the same extent as the wild-type cells. Genomic DNA iso-
lated 90 min after MMS treatment showed some repair in
all the strains, as evidenced by the decreased mobility of
DNA. However, the DNA of wild-type strain moved the
slowest, showing maximum repair. At this stage,  4.5%,
2.8% and 13% of the wild-type, chl1 and mec1-1 cells had
segregated their respective DNA. The percentages of large-
budded cells in the cultures were 54, 57 and 31 respectively.
After 2 h of treatment, the mobilities of wild-type MMS-
treated and untreated DNA were almost the same. The
DNA from the mutant (chl1 and mec1-1) cells, however,
still exhibited higher mobilities indicative of preponderance
of lower molecular weight species due to defective repair.
At this time chl1 cells were still arrested at G2/M (81%
large-budded and only 3% of total cells had segregated
nuclei) but wild-type had initiated nuclear segregation (77%
large-budded cells and 10% of cells had segregated nuclei).
The mec1-1 culture had 67% large-budded cells and 33%
of the cells had segregated nuclei. This precocious segrega-
tion of damaged DNA would be one of the reasons why
Nucleic Acids Research, 2006, Vol. 34, No. 20 5887mec1-1 cells are much less viable than chl1 cells when chal-
lenged with MMS (Figure 5F). Thus, the FACS proﬁle
(Figure 5D) and nuclear morphologies showed that the major-
ity of wild-type and chl1 cells were still arrested at G2/M
after 2 h of recovery time. Yet there was an upward shift
of DNA in this period. The simplest explanation is that
while the cells were resting at G2/M, the DNA was getting
continuously repaired. This repair was sluggish in the mutant
cells. Thus, Chl1p is required for efﬁcient repair of MMS-
induced DNA damage.
Figure 5. Chl1p is required for DNA damage repair in S-phase. (A) A schematic representation of the mechanism by which alkylated DNA can give rise to nicks,
gaps and double-strand breaks, resulting in higher mobility of genomic DNA during agarose gel electrophoresis. Alkylated bases are cleaved by DNA
glycosylases creating apurinic or apyrimidinic (AP) sites which are cleaved by AP endonuclease/lyase giving rise to single-strand breaks. Closely opposed and
unrepaired single-strand breaks (SSB), coupled with the stalling of replication forks at alkylated bases can give rise to double-strand breaks in DNA (59) which
are repaired in the wild-type but not in the mutant. (B and C) Overnight cultures of wild-type (SL14) and mutant strains chl1 (SL14Dchl1) grown at 30 Ci n
liquid YEPD were re-inoculated in YEPD at 30 C till mid-log-phase (OD610 ﬃ 0.8–1) and synchronized in G1 using alpha-factor. Cells were released from arrest
in liquid YEPD at 30 C in the presence or absence of varying concentrations of MMS. At indicated times, aliquots were taken out for FACS analysis (C) and to
isolate DNA in agarose plugs as described in Methods section. Agarose gel (0.5%) electrophoresis of DNA was carried out for 28 h at 2.5 V/cm, as described
under Methods (B). (D) Overnight cultures of wild-type (SL14) and mutant strains chl1 (SL14Dchl1) and mec1-1 (US3138), grown at 23 C in liquid YEPD were
re-inoculated in YEPD at 28 C till mid-log phase (OD610 ﬃ 0.8–1) and synchronized in G1 using alpha-factor. Cells were released from arrest in liquid YEPD at
28 C in the presence or absence of 0.035% MMS. At indicated times, aliquots were taken out for FACS analysis (D) and to isolate DNA in agarose plugs as
described in Methods. (E) Agarose gel electrophoresis of the DNA in plugs from (D) was carried out as described above. There were no differences in the
mobilities of genomic DNA isolated from cultures not exposed to MMS at all time points in the experiment. DNA from untreated cells ( MMS) corresponds to
genomic DNA isolated 1.5 h after release from arrest of untreated cells, that is, 1 h after MMS wash. ‘ ’ indicates no MMS was added while ‘+’ indicates MMS
added. (F) Growth of wild-type SL14 (CHL1 MEC1), SL14Dchl1 (chl1 MEC1) and US3138 (mec1-1) on YEPD plates with or without 0.01% MMS. Plates were
incubated for 3 days at 23 C. (G) Agarose gel electrophoresis (as described above) of DNA isolated in plugs from wild-type (A3), chl1 (A3Dchl1), mcm2-1
(SL13) and mcm2-1 chl1 (SL13Dchl1) cells grown in liquid YEPD at 32 C for 24 h.
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damaged DNA when grown at semi-permissive temperatures
(46). Genomic DNA isolated from mcm2-1 cells moves faster
on agarose gels [(46), Figure 5G] and this phenotype is sup-
pressed by minichromosomes carrying the MCM2 gene (60).
In this work, we found that mcm2-1 chl1 mutant, when cul-
tured at 32 C, accumulates large-budded cells containing
fragmented nuclei (Figure 2C). When DNA of such cells
was isolated in agarose plugs, it showed even higher mobility
than mcm2-1 DNA (Figure 5G), conﬁrming that in the
absence of Chl1p, mcm2-1 cells are unable to repair DNA
damage that arises due to the absence of Mcm2p activity.
DISCUSSION
Earlier work on the budding yeast protein, Chl1p, has impli-
cated its role in sister-chromatid cohesion, chromatin
structure, rDNA recombination and aging. In this work, we
ascribe additional roles to Chl1p in the budding yeast cell
cycle. We show that this protein is required in S-phase to
maintain cell viability if DNA replication is put under stress
due to mutations or by treatment with genotoxic agents
like UV radiation and MMS. All these observations are con-
sistent with a role of Chl1p in DNA replication, repair or
checkpoint function. Since chl1 mutation does not elevate
genetic recombination frequency signiﬁcantly (29,51), nor
does it slow down S-phase, Chl1p does not appear to have
a role in bulk DNA synthesis under normal conditions of
growth. In the presence of MMS, the absence of Chl1p led
to a loss in cell viability in S-phase but the DNA damage
checkpoint pathway remained fully active. The double mut-
ant rad53-21 chl1 showed higher cell death than the single
mutant rad53-21 that lacks a functional DNA damage check-
point pathway (55). This observation is strongly suggestive of
Chl1p’s involvement in checkpoint-independent MMS-
induced DNA damage repair. Agarose gel electrophoresis
of genomic DNA isolated from MMS-treated S-phase cells,
which were allowed to repair the DNA damage, showed
that chl1 cells were less proﬁcient than the wild-type in
repairing the damage. Similar results were obtained with
the mec1-1 mutant, which is known to be defective in the
repair of damaged DNA, lending credence to the theory
that Chl1p is required for DNA damage repair.
It is interesting that MMS-treated genomic DNA moved
primarily as a band (with some evidence of smearing below
the band, Figure 5B) and was not highly degraded into a low
molecular weight smear. Each such band would actually
consist of a range of high molecular weight DNA molecules
which, just like untreated genomic DNA, cannot be resolved
by simple agarose gel electrophoresis. The absence of promi-
nent smears ﬂanking the band was indicative of a relatively
narrow distribution of DNA size in that band, the reason
for which is not immediately clear. Nevertheless, the mobility
shift experiments indicated that the average size of
DNA decreased with increasing concentrations of MMS.
We believe that the average molecular weight of DNA
from MMS-treated cells remains high because the treatment
is for a limited period of time with low concentrations of
MMS. DNA could be protected against heavy damage
because not all hits by MMS may result in DNA alkylation;
DNA organized into chromatin within the cell could be less
accessible to MMS due to the surrounding milieu which
may not favor the alkylation reaction. Furthermore, a simul-
taneous repair process could protect DNA from extensive
fragmentation during MMS treatment. This repair could
help to prevent the degradation of DNA into low molecular
weight species. This approach should be of use to study the
response of cells in relation to DNA damage when they are
exposed to different levels of this drug.
One of the reasons for the observed synthetic lethal or sick
interactions of chl1 with DNA replication mutations could
simply be due to the inability of the double mutants to repair
damaged DNA. This was corroborated by the ﬁnding that
these cells showed fragmented nuclei with loss in viability
when grown at semi-permissive temperatures and that
mcm2-1 chl1 cells synthesized DNA which migrated faster
than mcm2-1 DNA in 0.5% agarose gels. The mutational alle-
les mcm2-1, orc2-1 and orc5-1, all lead to under initiations at
yeast replication origins (50,61,62). In contrast, cdc6-3 is a
gain of function allele which allows promiscuous initiation
of DNA replication even in G2/M (63). This allele causes
cell death at high temperatures, very likely due to a lack of
genomic integrity caused by continued re-replications
(63,64). At non-permissive temperatures, cells carrying any
of these mutations do not enter mitosis and arrest as large-
budded cells, each having a single nucleus. The presence of
DNA damage in mcm2-1 and orc2-1 has been documented
(46,49,65,66). It has been shown that the spindle checkpoint-
dependent G2/M arrest observed at non-permissive tempera-
tures in orc5-1 cells is also elicited due to DNA damage as
a result of extended S-phase (67,68). We believe that in
the absence of Chl1p and at semi-permissive temperatures,
the DNA damage was extensive in these mutants, leading
to lower cell viabilities and high incidence of nuclear frag-
mentation. Nuclear fragmentation in double mutants could
not have occurred due to prolonged arrest at G2/M, since a
high percentage of cdc6-3 cells were also arrested at G2/M
but did not show signiﬁcant levels of nuclear fragmentation.
It remains to be seen whether this phenotype constitutes
apoptosis-like death in the double mutants (66).
Recently, a number of DNA replication checkpoint pro-
teins have been identiﬁed which help in the maintenance of
sister-chromatid cohesion (69). Damaged DNA could well
affect the loading of cohesin complex, leading to cohesion
defects. The physical association of Chl1p with Ctf7, which
itself associates with RF-C factors when bound to Rad24p
or Ctf18p (70), is strongly suggestive of the presence of
Chl1p at replication forks which stall due to DNA damage.
Its helicase activity may be required to unwind DNA so
that alternative structures could be formed at the fork that
mediate either checkpoint proteins/cohesin loading or facili-
tate DNA repair. In another recent study, Suter et al. (71)
have found synthetic lethal or sick interactions between muta-
tions in CTF4, CTF8, CTF18 and DCC1 (genes involved in
sister-chromatid cohesion) and mutations in genes required
for DNA replication initiation, suggesting that robust
cohesion and the integrity of DNA being synthesized are
interdependent. Furthermore, loading of fresh cohesin is
needed for the repair of double-strand DNA breaks (72,73).
Since Chl1p is also required for sister-chromatid cohesion,
improper cohesin loading at sites of DNA damage could be
Nucleic Acids Research, 2006, Vol. 34, No. 20 5889instrumental in defective DNA repair leading to cell death,
and thus this protein may be playing an indirect role in
DNA repair. One of the ways by which the interplay between
MMS sensitivity and cohesion defects can be studied is by
analyzing phenotypes of a large number of chl1 point muta-
tions to see if the two phenotypes are always linked. Experi-
ments involving synergism between chl1 and cohesion
mutations like ctf4 will also be of great help in answering
the question whether Chl1p is directly involved in DNA
repair or this phenotype is due to cohesion defects. These
experiments are in progress.
Chl1p has a human homolog, BACH1, which is a DNA
helicase and binds to the breast tumour suppressor protein
BRCA1, contributing towards its DNA repair function
(38,74). Germline mutations that target its helicase activity
were found in the BACH1 gene of some patients having
early onset of breast cancer (74). Our work shows a similar
role for Chl1p. Further work on yeast Chl1p will throw
more light on the molecular mechanisms which interlink
sister-chromatid cohesion, transcriptional silencing and
DNA damage repair.
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